ClinicalTrials.Veeva

Menu

Serial Phlebotomy in Voluntary Blood Donors

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Atherosclerosis

Treatments

Other: Phlebotomy

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02762422
1R01HL086932 (U.S. NIH Grant/Contract)
08-411
UL1TR000038 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Blood donation has been proposed to be associated with reduced risk of cardiovascular disease, but the effects of phlebotomy on vascular function in human subjects have not been well characterized. A prospective randomized double-blind study was undertaken to determine the effects of iron loss and red blood cell loss induced by serial phlebotomy on vascular endothelial function in the brachial artery.

Full description

84 Fe-replete, non-anemic subjects were randomly assigned to one of three experimental serial phlebotomy procedures designed to induce Fe loss or RBC loss. Brachial artery reactivity (BAR, %) in response to transient oxidative stress induced by oral methionine was measured with high-resolution duplex ultrasound imaging before and after study phlebotomy procedures.

Enrollment

84 patients

Sex

All

Ages

40 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • hemoglobin levels >13.5 g/dl for men, or >12.5 g/dl for women
  • serum ferritin 50-400 ng/ml

Exclusion criteria

  • known intolerance of phlebotomy procedures
  • major trauma or surgical procedures in the last 2 years
  • menstrual or other uterine bleeding in the last 2 years
  • chronic oral anticoagulation or dual antiplatelet therapy
  • chronic non-steroidal anti-inflammatory drug use
  • known history of hemochromatosis or other disorder of hematopoiesis or Fe metabolism
  • chronic oral Fe supplementation other than Fe-containing multivitamins
  • history of active cancer in the past 2 years
  • known history of chronic inflammatory disease
  • uncontrolled hypertension
  • electrocardiographic evidence of prior myocardial infarction
  • diabetes mellitus
  • fasting glucose >100 mg/dL
  • body mass index >40 kg/m2
  • any tobacco use in the past 6 months

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

84 participants in 3 patient groups, including a placebo group

Phlebotomy plus normal saline
Experimental group
Description:
Four serial phlebotomy procedures followed by infusion of normal saline
Treatment:
Other: Phlebotomy
Phlebotomy plus intravenous iron
Experimental group
Description:
Four serial phlebotomy procedures followed by infusion of intravenous iron sucrose
Treatment:
Other: Phlebotomy
Sham Phlebotomy
Placebo Comparator group
Description:
Four serial sham phlebotomy procedures followed by infusion of normal saline
Treatment:
Other: Phlebotomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems